Abstract
OBJECTIVES: This study sought to determine the prevalence and determinants of use of recommended antiretroviral regimens among urban seropositive men who have sex with men (MSM). METHODS: A probability telephone sample of MSM was taken within regions of Chicago, Los Angeles, New York, and San Francisco. Analysis focused on use of antiretroviral therapies. RESULTS: Although the majority of seropositive MSM with CD4 counts below 500 per microliter were using recommended antiretroviral regimens, 26% of seropositive MSM were not receiving such care. Men who were younger, who reported a sexual orientation other than homosexual, who had a more recent interview date, who were at middle levels of affiliation with the gay community, and who reported higher levels of perceived exclusivity on the part of the gay community were less likely to be using recommended antiretroviral regimens. CONCLUSIONS: Although current efforts to make antiretroviral therapies available to HIV-seropositive MSM are reasonably effective, additional efforts are needed for MSM characterized by relative youth and lower social support.
Full Text
The Full Text of this article is available as a PDF (85.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. E., Nelson D. E., Wilson R. W. Telephone coverage and measurement of health risk indicators: data from the National Health Interview Survey. Am J Public Health. 1998 Sep;88(9):1392–1395. doi: 10.2105/ajph.88.9.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bozzette S. A., Berry S. H., Duan N., Frankel M. R., Leibowitz A. A., Lefkowitz D., Emmons C. A., Senterfitt J. W., Berk M. L., Morton S. C. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998 Dec 24;339(26):1897–1904. doi: 10.1056/NEJM199812243392606. [DOI] [PubMed] [Google Scholar]
- Cameron D. W., Heath-Chiozzi M., Danner S., Cohen C., Kravcik S., Maurath C., Sun E., Henry D., Rode R., Potthoff A. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet. 1998 Feb 21;351(9102):543–549. doi: 10.1016/s0140-6736(97)04161-5. [DOI] [PubMed] [Google Scholar]
- Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Sáag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA. 1996 Jul 10;276(2):146–154. [PubMed] [Google Scholar]
- Catania J. A., Gibson D. R., Chitwood D. D., Coates T. J. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull. 1990 Nov;108(3):339–362. doi: 10.1037/0033-2909.108.3.339. [DOI] [PubMed] [Google Scholar]
- Celentano D. D., Vlahov D., Cohn S., Shadle V. M., Obasanjo O., Moore R. D. Self-reported antiretroviral therapy in injection drug users. JAMA. 1998 Aug 12;280(6):544–546. doi: 10.1001/jama.280.6.544. [DOI] [PubMed] [Google Scholar]
- Ekstrand M. L., Stall R. D., Paul J. P., Osmond D. H., Coates T. J. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS. 1999 Aug 20;13(12):1525–1533. doi: 10.1097/00002030-199908200-00013. [DOI] [PubMed] [Google Scholar]
- Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997 Sep 11;337(11):734–739. doi: 10.1056/NEJM199709113371102. [DOI] [PubMed] [Google Scholar]
- Hammer S. M., Squires K. E., Hughes M. D., Grimes J. M., Demeter L. M., Currier J. S., Eron J. J., Jr, Feinberg J. E., Balfour H. H., Jr, Deyton L. R. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997 Sep 11;337(11):725–733. doi: 10.1056/NEJM199709113371101. [DOI] [PubMed] [Google Scholar]
- Kegeles S. M., Hays R. B., Coates T. J. The Mpowerment Project: a community-level HIV prevention intervention for young gay men. Am J Public Health. 1996 Aug;86(8):1129–1136. doi: 10.2105/ajph.86.8_pt_1.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Osmond D. H., Catania J., Pollack L., Canchola J., Jaffe D., MacKellar D., Valleroy L. Obtaining HIV test results with a home collection test kit in a community telephone sample. J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):363–368. doi: 10.1097/00126334-200008010-00011. [DOI] [PubMed] [Google Scholar]
- Ryff C. D., Keyes C. L. The structure of psychological well-being revisited. J Pers Soc Psychol. 1995 Oct;69(4):719–727. doi: 10.1037//0022-3514.69.4.719. [DOI] [PubMed] [Google Scholar]
- Shapiro M. F., Morton S. C., McCaffrey D. F., Senterfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999 Jun 23;281(24):2305–2315. doi: 10.1001/jama.281.24.2305. [DOI] [PubMed] [Google Scholar]
- Strathdee S. A., Palepu A., Cornelisse P. G., Yip B., O'Shaughnessy M. V., Montaner J. S., Schechter M. T., Hogg R. S. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998 Aug 12;280(6):547–549. doi: 10.1001/jama.280.6.547. [DOI] [PubMed] [Google Scholar]